Newly Approved Lupus Drug Based on Discoveries Made in HSS Lab
Much of the groundwork for the development of this drug was done in laboratories at Hospital for Special Surgery (HSS) in the early 2000s.
- Much of the groundwork for the development of this drug was done in laboratories at Hospital for Special Surgery (HSS) in the early 2000s.
- In lupus, however, this receptor is activated even when no infection is present, causing the immune system to instead attack its host.
- In the lab, Dr. Crow and her team began studying the blood of people with lupus and comparing it to the blood of healthy individuals.
- In 2003, Dr. Crow and her HSS team were one of three groups to publish research confirming interferon's pivotal role in lupus.